Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Subscribe to Free Drug Patent Expiration Updates

Also available in a Drug Patent Expiration NewsletterRSS feed and on Drug Patent Expirations on TwitterTwitter

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: PROPULSID QUICKSOLV

« Back to Dashboard
Propulsid Quicksolv is a drug marketed by Janssen Pharma and is included in one NDA. There is one patent protecting this drug.

This drug has fifty-three patent family members in thirty countries.

The generic ingredient in PROPULSID QUICKSOLV is cisapride monohydrate. There is one drug master file entry for this compound. Additional details are available on the cisapride monohydrate profile page.

Summary for Tradename: PROPULSID QUICKSOLV


Clinical Trials for: PROPULSID QUICKSOLV

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharma
cisapride monohydrate
TABLET, ORALLY DISINTEGRATING;ORAL020767-001Nov 7, 1997DISCNNo5,648,093<disabled> <disabled>
This preview shows a limited data set
Subscribe for full access

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: PROPULSID QUICKSOLV

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,120,549 United States Patent: 5120549   ( 1<disabled in preview>
5,558,880 Pharmaceutical and other dosage forms<disabled in preview>
5,330,763 Delivery matrices prepared by solid-state dissolution<disabled in preview>
5,330,764 Methods of preparing bulk delivery matrices by solid-state dissolution<disabled in preview>
5,215,756 Preparation of pharmaceutical and other matrix systems by solid-state dissolution<disabled in preview>
This preview shows a limited data set
Subscribe for full access

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PROPULSID QUICKSOLV

Country Document Number Publication Date
Finland945198Nov 04, 1994
Singapore49249May 18, 1998
Chile2004001180Jun 03, 2005
World Intellectual Property Organization (WIPO)9323017Nov 25, 1993
Denmark0460185Sep 27, 1999
This preview shows a limited data set
Subscribe for full access

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn